ADC Therapeutics

Company Snapshot
Route de la Corniche 3B
Epalinges, 1066
Switzerland
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 125
https://www.adctherapeutics.com
Please select from the dropdown
  1. Executive Compensation
  2. > ADC Therapeutics
Company Financials

2021
2022
2023
Gross Profit
$32,524,000
$205,329,000
$67,029,000
Operating Income
-$261,720,000
-$123,627,000
-$165,051,000
Net Income
-$230,026,000
-$155,800,000
-$240,053,000
2021
Gross Profit
$32,524,000
Operating Income
-$261,720,000
Net Income
-$230,026,000
2022
Gross Profit
$205,329,000
Operating Income
-$123,627,000
Net Income
-$155,800,000
2023
Gross Profit
$67,029,000
Operating Income
-$165,051,000
Net Income
-$240,053,000
The above data on ADC Therapeutics came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Mohamed Zaki
Chief Medical Officer
$2,398,542
$1,989,900
$15,409
$4,403,851
Mohamed Zaki
$4,403,851
Chief Medical Officer
Ameet Mallik
Chief Executive Officer and Director
$1,793,775
$1,940,550
$45,100
$3,779,425
Ameet Mallik
$3,779,425
Chief Executive Officer and Director
Jose Carmona
Chief Financial Officer
$864,000
$374,500
$20,857
$1,259,357
Jose Carmona
$1,259,357
Chief Financial Officer
Ron Squarer
Chairman of the Board
$440,519
$45,800
$40,407
$526,726
Ron Squarer
$526,726
Chairman of the Board
Victor Sandor
Independent Director
$59,923
$137,800
$30,000
$227,723
Victor Sandor
$227,723
Independent Director
ADC Therapeutics listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2023. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us